Vault-13

Artal Group S.A.

LUXEMBOURG, N4 · CIK 1053906 · 13F filing filed 2022-08-11

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$1.8bn reported value -24.0% vs Q1 2022
132positions
51.0%in top 10
5 new 7 added 8 reduced 8 sold out vs Q1 2022

Options: 3 call positions ($73.9m notional), 0 put positions (— notional) – listed below, not included above.

This report includes the holdings of 6 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARGENX SE SPONSORED ADR ARGX ARGX 400,000 $151.6m8.43% 8.43% ReducedShares held: Q3 2021 577.3k, Q4 2021 500.0k, Q1 2022 587.5k, Q2 2022 400.0k -187.5k -187,500 -31.9%
2 LEXICON PHARMACEUTICALS INC COM NEW LXRX LXRX 71,178,364 $132.4m7.36% 7.36% UnchangedShares held: Q3 2021 71.2m, Q4 2021 71.2m, Q1 2022 71.2m, Q2 2022 71.2m
3 BEIGENE LTD SPONSORED ADR ONC ONC 650,000 $105.2m5.85% 5.85% ReducedShares held: Q3 2021 650.0k, Q4 2021 675.0k, Q1 2022 665.0k, Q2 2022 650.0k -15.0k -15,000 -2.3%
4 WW INTL INC COM WTW WTW 14,818,300 $94.7m5.27% 5.27% UnchangedShares held: Q3 2021 14.8m, Q4 2021 14.8m, Q1 2022 14.8m, Q2 2022 14.8m
5 SEAGEN INC COM SGEN SGEN 525,000 $92.9m5.17% 5.17% ReducedShares held: Q3 2021 375.0k, Q4 2021 500.0k, Q1 2022 650.0k, Q2 2022 525.0k -125.0k -125,000 -19.2%
6 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 600,000 $87.5m4.87% 4.87% ReducedShares held: Q3 2021 700.0k, Q4 2021 650.0k, Q1 2022 650.0k, Q2 2022 600.0k -50.0k -50,000 -7.7%
7 MIRATI THERAPEUTICS INC COM MRTX MRTX 1,100,000 $73.8m4.11% 4.11% ReducedShares held: Q3 2021 1.2m, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 1.1m -250.0k -250,000 -18.5%
8 BELLUS HEALTH INC NEW COM NEW BLU BLU 7,000,000 $64.7m3.60% 3.60% ReducedShares held: Q3 2021 5.2m, Q4 2021 8.5m, Q1 2022 8.5m, Q2 2022 7.0m -1.5m -1,500,000 -17.6%
9 FATE THERAPEUTICS INC COM FATE FATE 2,600,000 $64.4m3.58% 3.58% AddedShares held: Q3 2021 1.4m, Q4 2021 1.8m, Q1 2022 2.0m, Q2 2022 2.6m +600.0k +600,000 30.0%
10 CYTOKINETICS INC COM NEW CYTK CYTK 1,275,000 $50.1m2.79% 2.79% AddedShares held: Q3 2021 1.3m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.3m +275.0k +275,000 27.5%
11 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 8,750,034 $48.0m2.67% 2.67% AddedShares held: Q3 2021 1.9m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 8.8m +6.3m +6,300,034 257.1%
12 AMICUS THERAPEUTICS INC COM FOLD FOLD 4,000,000 $43.0m2.39% 2.39% UnchangedShares held: Q3 2021 6.7m, Q4 2021 6.0m, Q1 2022 4.0m, Q2 2022 4.0m
13 SEER INC COM CL A SEER SEER 4,750,000 $42.5m2.36% 2.36% UnchangedShares held: Q3 2021 4.8m, Q4 2021 4.8m, Q1 2022 4.8m, Q2 2022 4.8m
14 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 1,500,000 $39.7m2.21% 2.21% UnchangedShares held: Q3 2021 1.8m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
15 IGM BIOSCIENCES INC COM IGMS IGMS 2,000,000 $36.1m2.01% 2.01% UnchangedShares held: Q3 2021 1.4m, Q4 2021 1.5m, Q1 2022 2.0m, Q2 2022 2.0m
16 MORPHIC HLDG INC COM MORF MORF 1,650,000 $35.8m1.99% 1.99% UnchangedShares held: Q3 2021 1.6m, Q4 2021 1.6m, Q1 2022 1.6m, Q2 2022 1.6m
17 KRYSTAL BIOTECH INC COM KRYS KRYS 500,000 $32.8m1.83% 1.83% UnchangedShares held: Q3 2021 500.0k, Q4 2021 700.0k, Q1 2022 500.0k, Q2 2022 500.0k
18 FOGHORN THERAPEUTICS INC COM FHTX FHTX 1,720,720 $23.4m1.30% 1.30% UnchangedShares held: Q3 2021 1.7m, Q4 2021 1.7m, Q1 2022 1.7m, Q2 2022 1.7m
19 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 900,000 $22.2m1.23% 1.23% AddedShares held: Q3 2021 600.0k, Q4 2021 850.0k, Q1 2022 850.0k, Q2 2022 900.0k +50.0k +50,000 5.9%
20 GOSSAMER BIO INC COM GOSS GOSS 2,358,968 $19.7m1.10% 1.10% UnchangedShares held: Q3 2021 2.4m, Q4 2021 2.4m, Q1 2022 2.4m, Q2 2022 2.4m
21 KYMERA THERAPEUTICS INC COM KYMR KYMR 1,000,000 $19.7m1.09% 1.09% UnchangedShares held: Q3 2021 400.0k, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
22 KURA ONCOLOGY INC COM KURA KURA 1,050,000 $19.2m1.07% 1.07% UnchangedShares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m
23 EQRX INC COM COM 4,000,000 $18.8m1.04% 1.04% UnchangedShares held: Q3 2021 0, Q4 2021 4.0m, Q1 2022 4.0m, Q2 2022 4.0m
24 SCHRODINGER INC COM SDGR SDGR 700,000 $18.5m1.03% 1.03% UnchangedShares held: Q3 2021 700.0k, Q4 2021 700.0k, Q1 2022 700.0k, Q2 2022 700.0k
25 GENERATION BIO CO COM COM 2,814,191 $18.5m1.03% 1.03% UnchangedShares held: Q3 2021 2.8m, Q4 2021 2.8m, Q1 2022 2.8m, Q2 2022 2.8m
26 ERASCA INC COM ERAS ERAS 3,172,221 $17.7m0.98% 0.98% UnchangedShares held: Q3 2021 3.2m, Q4 2021 3.2m, Q1 2022 3.2m, Q2 2022 3.2m
27 DENALI THERAPEUTICS INC COM DNLI DNLI 600,000 $17.7m0.98% 0.98% UnchangedShares held: Q3 2021 500.0k, Q4 2021 600.0k, Q1 2022 600.0k, Q2 2022 600.0k
28 REPLIMUNE GROUP INC COM REPL REPL 900,000 $15.7m0.87% 0.87% UnchangedShares held: Q3 2021 900.0k, Q4 2021 900.0k, Q1 2022 900.0k, Q2 2022 900.0k
29 SAGE THERAPEUTICS INC COM SAGE SAGE 450,000 $14.5m0.81% 0.81% ReducedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 750.0k, Q2 2022 450.0k -300.0k -300,000 -40.0%
30 INTELLIA THERAPEUTICS INC COM NTLA NTLA 275,000 $14.2m0.79% 0.79% UnchangedShares held: Q3 2021 275.0k, Q4 2021 275.0k, Q1 2022 275.0k, Q2 2022 275.0k
31 EVOTEC AG SPONSORED ADS EVO EVO 1,149,425 $13.8m0.77% 0.77% UnchangedShares held: Q3 2021 0, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m
32 RELAY THERAPEUTICS INC COM RLAY RLAY 700,000 $11.7m0.65% 0.65% UnchangedShares held: Q3 2021 400.0k, Q4 2021 750.0k, Q1 2022 700.0k, Q2 2022 700.0k
33 MERSANA THERAPEUTICS INC COM COM 2,200,000 $10.2m0.57% 0.57% UnchangedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 2.2m, Q2 2022 2.2m
34 AURINIA PHARMACEUTICALS INC COM AUPH AUPH 1,000,000 $10.1m0.56% 0.56% UnchangedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
35 REPARE THERAPEUTICS INC COM RPTX RPTX 700,000 $9.8m0.54% 0.54% UnchangedShares held: Q3 2021 550.0k, Q4 2021 700.0k, Q1 2022 700.0k, Q2 2022 700.0k
36 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 3,000,000 $9.8m0.54% 0.54% AddedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 3.0m +2.0m +2,000,000 200.0%
37 I MAB SPONSORED ADS NBP NBP 850,000 $9.6m0.53% 0.53% UnchangedShares held: Q3 2021 825.0k, Q4 2021 850.0k, Q1 2022 850.0k, Q2 2022 850.0k
38 TALARIS THERAPEUTICS INC COM COM 2,064,262 $9.3m0.52% 0.52% UnchangedShares held: Q3 2021 2.1m, Q4 2021 2.1m, Q1 2022 2.1m, Q2 2022 2.1m
39 ALLOVIR INC COM COM 2,323,371 $9.1m0.50% 0.50% UnchangedShares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
40 OMEGA THERAPEUTICS INC COMMON STOCK COMMON STOCK 2,273,530 $8.6m0.48% 0.48% UnchangedShares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
41 ITEOS THERAPEUTICS INC COM ITOS ITOS 400,000 $8.2m0.46% 0.46% UnchangedShares held: Q3 2021 994.0k, Q4 2021 544.0k, Q1 2022 400.0k, Q2 2022 400.0k
42 ATARA BIOTHERAPEUTICS INC COM COM 1,000,000 $7.8m0.43% 0.43% UnchangedShares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.0m, Q2 2022 1.0m
43 OMEGA ALPHA SPAC CL A CL A 750,000 $7.4m0.41% 0.41% UnchangedShares held: Q3 2021 750.0k, Q4 2021 750.0k, Q1 2022 750.0k, Q2 2022 750.0k
44 IKENA ONCOLOGY INC COM COM 1,549,513 $6.9m0.38% 0.38% UnchangedShares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
45 SELECTA BIOSCIENCES INC COM COM 4,883,200 $6.4m0.36% 0.36% AddedShares held: Q3 2021 4.0m, Q4 2021 4.0m, Q1 2022 4.0m, Q2 2022 4.9m +883.2k +883,200 22.1%
46 VERVE THERAPEUTICS INC COM COM 400,000 $6.1m0.34% 0.34% UnchangedShares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
47 Y-MABS THERAPEUTICS INC COM YMAB YMAB 400,000 $6.1m0.34% 0.34% UnchangedShares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
48 EXSCIENTIA PLC ADS EXAI EXAI 550,000 $6.0m0.33% 0.33% UnchangedShares held: Q3 2021 0, Q4 2021 550.0k, Q1 2022 550.0k, Q2 2022 550.0k
49 AGENUS INC COM NEW COM NEW 3,000,000 $5.8m0.32% 0.32% ReducedShares held: Q3 2021 5.5m, Q4 2021 6.5m, Q1 2022 5.5m, Q2 2022 3.0m -2.5m -2,500,000 -45.5%
50 AMBRX BIOPHARMA INC SPONSORED ADS SPONSORED ADS 2,152,291 $5.7m0.32% 0.32% UnchangedShares held: Q3 2021 850.0k, Q4 2021 2.2m, Q1 2022 2.2m, Q2 2022 2.2m
51 ACHILLES THERAPEUTICS PLC SPONSORED ADS SPONSORED ADS 2,255,375 $5.7m0.32% 0.32% UnchangedShares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
52 KRONOS BIO INC COM KRON KRON 1,542,954 $5.6m0.31% 0.31% UnchangedShares held: Q3 2021 1.3m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
53 DESIGN THERAPEUTICS INC COM DSGN DSGN 400,000 $5.6m0.31% 0.31% UnchangedShares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
54 OVID THERAPEUTICS INC COM OVID OVID 2,500,000 $5.4m0.30% 0.30% UnchangedShares held: Q3 2021 2.5m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 2.5m
55 OATLY GROUP AB SPONSORED ADS SPONSORED ADS 1,500,000 $5.2m0.29% 0.29% UnchangedShares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
56 SQZ BIOTECHNOLOGIES CO COM SQZB SQZB 1,606,309 $5.1m0.28% 0.28% UnchangedShares held: Q3 2021 1.6m, Q4 2021 1.6m, Q1 2022 1.6m, Q2 2022 1.6m
57 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 593,030 $5.0m0.28% 0.28% UnchangedShares held: Q3 2021 593.0k, Q4 2021 593.0k, Q1 2022 593.0k, Q2 2022 593.0k
58 MARINUS PHARMACEUTICALS INC COM NEW MRNS MRNS 1,000,000 $4.8m0.27% 0.27% UnchangedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
59 CONTRAFECT CORP COM NEW CFRX CFRX 1,500,000 $4.6m0.26% 0.26% UnchangedShares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
60 LEAP THERAPEUTICS INC COM LPTX LPTX 4,000,000 $4.6m0.26% 0.26% UnchangedShares held: Q3 2021 4.0m, Q4 2021 4.0m, Q1 2022 4.0m, Q2 2022 4.0m
61 LYELL IMMUNOPHARMA INC COM COM 700,000 $4.6m0.25% 0.25% UnchangedShares held: Q3 2021 700.0k, Q4 2021 700.0k, Q1 2022 700.0k, Q2 2022 700.0k
62 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 1,646,517 $4.0m0.23% 0.23% UnchangedShares held: Q3 2021 1.6m, Q4 2021 1.6m, Q1 2022 1.6m, Q2 2022 1.6m
63 ALX ONCOLOGY HLDGS INC COM ALXO ALXO 500,000 $4.0m0.22% 0.22% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
64 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 1,040,882 $3.9m0.22% 0.22% UnchangedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
65 SYROS PHARMACEUTICALS INC COM SYRS SYRS 4,000,000 $3.9m0.21% 0.21% AddedShares held: Q3 2021 2.0m, Q4 2021 3.0m, Q1 2022 3.5m, Q2 2022 4.0m +500.0k +500,000 14.3%
66 SEA LTD SPONSORD ADS SE SE 57,500 $3.8m0.21% 0.21% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 57.5k, Q2 2022 57.5k
67 NANOBIOTIX SPONSORED ADS NBTX NBTX 1,000,000 $3.8m0.21% 0.21% UnchangedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
68 PORTAGE FINTECH ACQUISITN CO CLASS A ORD SHS PFTA PFTA 380,000 $3.7m0.21% 0.21% UnchangedShares held: Q3 2021 380.0k, Q4 2021 380.0k, Q1 2022 380.0k, Q2 2022 380.0k
69 RECURSION PHARMACEUTICALS IN CL A RXRX RXRX 450,000 $3.7m0.20% 0.20% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 450.0k, Q2 2022 450.0k
70 AVIDITY BIOSCIENCES INC COM RNA RNA 250,000 $3.6m0.20% 0.20% UnchangedShares held: Q3 2021 142.5k, Q4 2021 250.0k, Q1 2022 250.0k, Q2 2022 250.0k
71 AC IMMUNE SA SHS ACIU ACIU 1,000,000 $3.6m0.20% 0.20% UnchangedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
72 DYNE THERAPEUTICS INC COM DYN DYN 525,000 $3.6m0.20% 0.20% UnchangedShares held: Q3 2021 525.0k, Q4 2021 525.0k, Q1 2022 525.0k, Q2 2022 525.0k
73 ADVERUM BIOTECHNOLOGIES INC COM COM 3,000,000 $3.6m0.20% 0.20% UnchangedShares held: Q3 2021 3.0m, Q4 2021 3.0m, Q1 2022 3.0m, Q2 2022 3.0m
74 APTINYX INC COM COM 6,116,493 $3.4m0.19% 0.19% UnchangedShares held: Q3 2021 6.1m, Q4 2021 6.1m, Q1 2022 6.1m, Q2 2022 6.1m
75 STOKE THERAPEUTICS INC COM STOK STOK 250,000 $3.3m0.18% 0.18% UnchangedShares held: Q3 2021 250.0k, Q4 2021 250.0k, Q1 2022 250.0k, Q2 2022 250.0k
76 INVIVYD INC COM IVVD IVVD 1,000,000 $3.3m0.18% 0.18% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.0m, Q2 2022 1.0m
77 CULLINAN THERAPEUTICS INC COM CGEM CGEM 250,000 $3.2m0.18% 0.18% UnchangedShares held: Q3 2021 100.0k, Q4 2021 250.0k, Q1 2022 250.0k, Q2 2022 250.0k
78 RUBIUS THERAPEUTICS INC COM RUBY RUBY 3,701,580 $3.1m0.18% 0.18% UnchangedShares held: Q3 2021 4.2m, Q4 2021 3.7m, Q1 2022 3.7m, Q2 2022 3.7m
79 HOOKIPA PHARMA INC COM COM 1,849,616 $3.0m0.17% 0.17% UnchangedShares held: Q3 2021 599.6k, Q4 2021 599.6k, Q1 2022 1.8m, Q2 2022 1.8m
80 PRAXIS PRECISION MEDICINES I COM COM 1,200,000 $2.9m0.16% 0.16% UnchangedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
81 VIGIL NEUROSCIENCE INC COM VIGL VIGL 1,121,191 $2.9m0.16% 0.16% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.1m, Q2 2022 1.1m
82 MIRION TECHNOLOGIES INC COM CL A MIR MIR 500,000 $2.9m0.16% 0.16% UnchangedShares held: Q3 2021 0, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
83 VOR BIOPHARMA INC COM COM 550,000 $2.7m0.15% 0.15% UnchangedShares held: Q3 2021 550.0k, Q4 2021 550.0k, Q1 2022 550.0k, Q2 2022 550.0k
84 CINCOR PHARMA INC COM COM 137,010 $2.6m0.14% 0.14% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 137.0k
85 SANA BIOTECHNOLOGY INC COM SANA SANA 400,000 $2.6m0.14% 0.14% UnchangedShares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
86 IMMUNIC INC COM COM 700,000 $2.4m0.14% 0.14% UnchangedShares held: Q3 2021 700.0k, Q4 2021 700.0k, Q1 2022 700.0k, Q2 2022 700.0k
87 ZYMEWORKS INC COM ZYME ZYME 450,000 $2.4m0.13% 0.13% UnchangedShares held: Q3 2021 450.0k, Q4 2021 450.0k, Q1 2022 450.0k, Q2 2022 450.0k
88 BRIDGEBIO PHARMA INC COM BBIO BBIO 250,000 $2.3m0.13% 0.13% UnchangedShares held: Q3 2021 250.0k, Q4 2021 250.0k, Q1 2022 250.0k, Q2 2022 250.0k
89 TCR2 THERAPEUTICS INC COM TCRR TCRR 750,000 $2.2m0.12% 0.12% UnchangedShares held: Q3 2021 750.0k, Q4 2021 750.0k, Q1 2022 750.0k, Q2 2022 750.0k
90 INSTIL BIO INC COM COM 450,000 $2.1m0.12% 0.12% UnchangedShares held: Q3 2021 450.0k, Q4 2021 450.0k, Q1 2022 450.0k, Q2 2022 450.0k
91 SENTI BIOSCIENCES INC COM COM 1,055,555 $2.1m0.12% 0.12% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.1m
92 ADAGENE INC ADS ADAG ADAG 1,000,000 $2.1m0.11% 0.11% UnchangedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
93 IMMUTEP LTD SPONSORED ADS SPONSORED ADS 1,000,000 $2.0m0.11% 0.11% UnchangedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
94 111 INC ADS ADS 966,349 $2.0m0.11% 0.11% UnchangedShares held: Q3 2021 966.3k, Q4 2021 966.3k, Q1 2022 966.3k, Q2 2022 966.3k
95 NEXIMMUNE INC COM COM 1,200,000 $1.9m0.11% 0.11% UnchangedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
96 GRAPHITE BIO INC COM GRPH GRPH 700,000 $1.9m0.11% 0.11% UnchangedShares held: Q3 2021 700.0k, Q4 2021 700.0k, Q1 2022 700.0k, Q2 2022 700.0k
97 HARPOON THERAPEUTICS INC COM COM 1,000,000 $1.9m0.11% 0.11% UnchangedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
98 FUSION PHARMACEUTICALS INC COM COM 750,000 $1.9m0.10% 0.10% UnchangedShares held: Q3 2021 750.0k, Q4 2021 750.0k, Q1 2022 750.0k, Q2 2022 750.0k
99 SOLID BIOSCIENCES INC COM COM 3,000,000 $1.8m0.10% 0.10% UnchangedShares held: Q3 2021 3.0m, Q4 2021 3.0m, Q1 2022 3.0m, Q2 2022 3.0m
100 GRITSTONE BIO INC COM GRTS GRTS 750,000 $1.8m0.10% 0.10% UnchangedShares held: Q3 2021 0, Q4 2021 750.0k, Q1 2022 750.0k, Q2 2022 750.0k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
PROTAGONIST THERAPEUTICS INC PTGX PTGX 800,100 $18.9m800.1k shares
APELLIS PHARMACEUTICALS INC APLS APLS 200,000 $10.2m200.0k shares
FORMA THERAPEUTICS HLDGS INC 1,000,000 $9.3m1.0m shares
TG THERAPEUTICS INC TGTX TGTX 800,000 $7.6m800.0k shares
IMMUNOCORE HLDGS PLC IMCR IMCR 200,000 $6.0m200.0k shares
DYNAMICS SPECIAL PURPOSE COR 500,000 $4.9m500.0k shares
XP INC XP XP 35,000 $1.1m35.0k shares
GINKGO BIOWORKS HOLDINGS INC 50,000 $202.0k50.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
CITIGROUP INC C · Call CCall 1,000,000 $46.0m1.0m shares New
DIREXION SHS ETF TR LABU · Call LABUCall 4,000,000 $27.0m4.0m shares New
IGM BIOSCIENCES INC IGMS · Call IGMSCall 50,000 $902.0k50.0k shares New